| Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL) (NCT00800566) | M.D. Anderson Cancer Center | 2008-11-01 |
| Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia (NCT00782067) | Novartis Pharmaceuticals | 2008-10-13 |
| American Ginseng in Treating Patients With Fatigue Caused by Cancer (NCT00719563) | Alliance for Clinical Trials in Oncology | 2008-10-01 |
| Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer (NCT00782379) | Northside Hospital, Inc. | 2008-10-01 |
| Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy (NCT00509093) | Case Comprehensive Cancer Center | 2008-10-01 |
| Quality of Life in Younger Leukemia and Lymphoma Survivors (NCT00956475) | Case Comprehensive Cancer Center | 2008-10-01 |
| Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder (NCT00755040) | Vanderbilt-Ingram Cancer Center | 2008-10-01 |
| Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (NCT00809211) | Cancer Trials Ireland | 2008-10-01 |
| Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide (NCT00800839) | M.D. Anderson Cancer Center | 2008-09-01 |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking (NCT00790569) | Butler Hospital | 2008-09-01 |
| Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia (NCT00816283) | City of Hope Medical Center | 2008-09-01 |
| Blood Samples to Evaluate Biomarkers of Donor Chimerism (NCT00764829) | Fred Hutchinson Cancer Center | 2008-09-01 |
| A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors (NCT00756912) | Eisai Inc. | 2008-09-01 |
| Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer (NCT00816413) | University of Nebraska | 2008-09-01 |
| American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL (NCT00752895) | Wake Forest University Health Sciences | 2008-09-01 |
| Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL) (NCT00759798) | M.D. Anderson Cancer Center | 2008-08-13 |
| Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. (NCT00739141) | Memorial Sloan Kettering Cancer Center | 2008-08-12 |
| Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors (NCT00582816) | University of Wisconsin, Madison | 2008-08-01 |
| Decitabine, Cytarabine, GCSF for Refractory AML/MDS (NCT00740181) | Brown University | 2008-08-01 |
| Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia (NCT02007863) | University of Miami | 2008-08-01 |
| S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia (NCT00899743) | SWOG Cancer Research Network | 2008-08-01 |
| Blood Samples From Patients on a Clinical Trial to CINV During HSCT (NCT00900068) | OHSU Knight Cancer Institute | 2008-08-01 |
| Alemtuzumab + Rituximab Consolidation in CLL (NCT00771602) | M.D. Anderson Cancer Center | 2008-08-01 |
| Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT (NCT00709592) | Virginia Commonwealth University | 2008-07-21 |
| Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies (NCT00736749) | Children's Oncology Group | 2008-07-17 |
| Study of Bone Marrow Samples From Patients With Acute Leukemia (NCT00897559) | Eastern Cooperative Oncology Group | 2008-07-03 |
| Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial (NCT00890435) | Children's Oncology Group | 2008-07-01 |
| Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy (NCT00739388) | Swiss Cancer Institute | 2008-07-01 |
| Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes (NCT01029509) | M.D. Anderson Cancer Center | 2008-07-01 |
| A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer (NCT00754286) | Albert Einstein College of Medicine | 2008-07-01 |
| Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00669318) | Mayo Clinic | 2008-07-01 |
| Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI (NCT01602952) | Il-Yang Pharm. Co., Ltd. | 2008-07-01 |
| Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia (NCT00900224) | Alliance for Clinical Trials in Oncology | 2008-06-01 |
| Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant (NCT00725062) | Masonic Cancer Center, University of Minnesota | 2008-06-01 |
| Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases (NCT00813501) | City of Hope Medical Center | 2008-06-01 |
| 8-Chloro-Adenosine in Chronic Lymphocytic Leukemia (NCT00714103) | M.D. Anderson Cancer Center | 2008-06-01 |
| A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families (NCT00782145) | Tufts Medical Center | 2008-06-01 |
| Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms (NCT00665002) | H. Lee Moffitt Cancer Center and Research Institute | 2008-06-01 |
| Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia (NCT00607997) | Sunesis Pharmaceuticals | 2008-05-15 |
| Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT00707083) | Prince of Wales Hospital, Shatin, Hong Kong | 2008-05-01 |
| Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction (NCT00713505) | City of Hope Medical Center | 2008-05-01 |
| Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors (NCT00679536) | Ann & Robert H Lurie Children's Hospital of Chicago | 2008-05-01 |
| Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia (NCT00897182) | Alliance for Clinical Trials in Oncology | 2008-05-01 |
| Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze (NCT00634504) | BTG International Inc. | 2008-05-01 |
| Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers (NCT00770419) | Rutgers, The State University of New Jersey | 2008-05-01 |
| Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia (NCT00686218) | City of Hope Medical Center | 2008-05-01 |
| A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies (NCT01315132) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2008-04-10 |
| Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes (NCT00624936) | Ohio State University Comprehensive Cancer Center | 2008-04-01 |
| Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial (NCT00750009) | Case Comprehensive Cancer Center | 2008-04-01 |
| Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer (NCT00918658) | Case Comprehensive Cancer Center | 2008-04-01 |
| Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome (NCT00732316) | Asan Medical Center | 2008-04-01 |
| Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (NCT00723203) | City of Hope Medical Center | 2008-04-01 |
| Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome (NCT00731328) | Asan Medical Center | 2008-04-01 |
| Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT00651261) | Alliance for Clinical Trials in Oncology | 2008-04-01 |
| Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects (NCT00777530) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-04-01 |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT00558519) | Alliance for Clinical Trials in Oncology | 2008-03-12 |
| Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (NCT00576979) | City of Hope Medical Center | 2008-03-04 |
| Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients (NCT00631059) | University of California, Irvine | 2008-03-01 |
| A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS (NCT00656448) | M.D. Anderson Cancer Center | 2008-03-01 |
| Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas (NCT00647764) | Esanex Inc. | 2008-03-01 |
| Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT (NCT00648037) | Memorial Sloan Kettering Cancer Center | 2008-03-01 |
| Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation (NCT00620633) | Memorial Sloan Kettering Cancer Center | 2008-02-08 |
| Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer (NCT00516503) | Alliance for Clinical Trials in Oncology | 2008-02-01 |
| Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS) (NCT01222195) | M.D. Anderson Cancer Center | 2008-02-01 |
| Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant (NCT00597714) | David Rizzieri, MD | 2008-02-01 |
| Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia (NCT00553202) | Children's Oncology Group | 2008-01-01 |
| Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders (NCT00740467) | Institut Paoli-Calmettes | 2008-01-01 |
| Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (NCT00513747) | Alliance for Clinical Trials in Oncology | 2008-01-01 |
| Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant (NCT00513474) | Massachusetts General Hospital | 2008-01-01 |
| Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia (NCT00562328) | Mayo Clinic | 2008-01-01 |
| Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia (NCT00625729) | Masonic Cancer Center, University of Minnesota | 2008-01-01 |
| Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia (NCT00643240) | Masonic Cancer Center, University of Minnesota | 2008-01-01 |
| Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia (NCT00612612) | National Cancer Institute (NCI) | 2008-01-01 |
| Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors (NCT00566566) | Sheba Medical Center | 2008-01-01 |
| Clofarabine Bone Marrow Cytoreduction (NCT00724009) | University of Chicago | 2007-12-01 |
| Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic Leukemia (NCT00645606) | University Hospital, Tours | 2007-12-01 |
| Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT00516828) | NCIC Clinical Trials Group | 2007-11-27 |
| Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects (NCT00529763) | Bristol-Myers Squibb | 2007-11-17 |
| S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia (NCT00551460) | SWOG Cancer Research Network | 2007-11-15 |
| Investigation of the Cylex® ImmuKnow® Assay (NCT00569842) | Indiana University | 2007-11-01 |
| Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00577694) | UNC Lineberger Comprehensive Cancer Center | 2007-11-01 |
| Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia (NCT00665990) | St. Jude Children's Research Hospital | 2007-11-01 |
| Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP (NCT00564512) | French Innovative Leukemia Organisation | 2007-11-01 |
| Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia (NCT00898261) | ECOG-ACRIN Cancer Research Group | 2007-10-26 |
| A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan (NCT00577278) | City of Hope Medical Center | 2007-10-03 |
| Studying Fentanyl in Patients With Cancer (NCT00899951) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-10-01 |
| Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (NCT00982488) | Bristol-Myers Squibb | 2007-10-01 |
| T-Reg Cell Kinetics, Stem Cell Transplant, REGALE (NCT00578539) | Baylor College of Medicine | 2007-10-01 |
| Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen (NCT00556452) | University of Michigan Rogel Cancer Center | 2007-10-01 |
| T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE (NCT00578461) | Baylor College of Medicine | 2007-10-01 |
| Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older (NCT00535873) | M.D. Anderson Cancer Center | 2007-10-01 |
| Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders (NCT00801931) | Columbia University | 2007-09-06 |
| Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia (NCT00528450) | Memorial Sloan Kettering Cancer Center | 2007-09-01 |
| Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00555048) | Fred Hutchinson Cancer Center | 2007-09-01 |
| Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies (NCT00536978) | M.D. Anderson Cancer Center | 2007-09-01 |
| Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma (NCT00551239) | CTI BioPharma | 2007-08-01 |
| Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML (NCT00568633) | Stanford University | 2007-08-01 |
| Phase III Trial in Acute Promyelocytic Leukemia Patients (NCT00482833) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2007-08-01 |
| Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer (NCT00499668) | Vanderbilt-Ingram Cancer Center | 2007-08-01 |
| Acupuncture for Mucositis Pain in Cancer Care (NCT00549835) | Johns Hopkins University | 2007-08-01 |